{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:41:56Z","timestamp":1778078516987,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.vaccine.2021.10.020","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T09:29:08Z","timestamp":1634894948000},"page":"7466-7475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Would COVID-19 vaccination willingness increase if mobile technologies prohibit unvaccinated individuals from public spaces? A nationwide discrete choice experiment from China"],"prefix":"10.1016","volume":"40","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4691-7802","authenticated-orcid":false,"given":"Abram L.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5919-743X","authenticated-orcid":false,"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Jaime","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1407-7338","authenticated-orcid":false,"given":"Xinwen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6848-7714","authenticated-orcid":false,"given":"Shiqiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4651-9433","authenticated-orcid":false,"given":"Yihan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen W.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.10.020_b0005","unstructured":"World Health Organization (WHO). WHO Coronavirus Disease (COVID-19) Dashboard: Globally situation [Internet] 2021 June 7 [cited 2021 June 8]; Available from: https:\/\/covid19.who.int."},{"key":"10.1016\/j.vaccine.2021.10.020_b0010","doi-asserted-by":"crossref","unstructured":"Simmons B, Wentzel H, Mobarak S, Eslami G, Sadeghi A, Ali Asgari A, et al. Sofosbuvir\/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis. The Journal of antimicrobial chemotherapy [Internet]. 2021 Jan 19 [cited 2021 Apr 21];76(2):286\u201391. Available from: https:\/\/doi.org\/10.1093\/jac\/dkaa418.","DOI":"10.1093\/jac\/dkaa418"},{"key":"10.1016\/j.vaccine.2021.10.020_b0015","doi-asserted-by":"crossref","unstructured":"WHO Solidarity Trial Consortium. Repurposed antiviral drugs for COVID-19 - interim WHO solidarity trial results. N Engl J Med [Internet]. 2021 Feb 11 [cited 2021 Apr 21]. 384:497-511. Available from: https:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2023184.","DOI":"10.1056\/NEJMoa2023184"},{"key":"10.1016\/j.vaccine.2021.10.020_b0020","unstructured":"World Health Organization (WHO) COVID-19 vaccine tracker and landscape. [Internet] 2021 [cited 2021 June 8]; Available from: https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccine."},{"key":"10.1016\/j.vaccine.2021.10.020_b0025","unstructured":"Central People's Government of the People's Republic of China. In China, five novel Coronavirus vaccines have been approved for use with certain data supporting their safety and efficacy. \u6211\u56fd\u5df2\u6709\u4e94\u6b3e\u65b0\u51a0\u75c5\u6bd2\u75ab\u82d7\u83b7\u6279\u4f7f\u7528,\u5b89\u5168\u6027\u6709\u6548\u6027\u90fd\u6709\u4e00\u5b9a\u6570\u636e\u652f\u6491. [Internet]. 2021 Apr 5 [cited 2021 Apr 21]. Available from: http:\/\/www.gov.cn\/xinwen\/2021-04\/05\/content_5597802.htm."},{"key":"10.1016\/j.vaccine.2021.10.020_b0030","unstructured":"Central People's Government of the People's Republic of China. China pledges safety, effectiveness as vaccination to be carried out nationwide [Internet]. Beijing Xinhua; 2021 4 Jan [cited 2021 January 29]. Available from: http:\/\/english.www.gov.cn\/statecouncil\/ministries\/202101\/04\/content_WS5ff31ca0c6d0f72576943386.html."},{"key":"10.1016\/j.vaccine.2021.10.020_b0035","unstructured":"China Medical Resources. China 2nd COVID-19 inactivated vaccine approved with conditions. [Internet]. 2021 Feb 26 [cited 2021 Apr 21]; Available from: https:\/\/chinamedicals.org\/2021\/02\/26\/china-2nd-covid-19-inactivated-vaccine-approved-with-conditions\/."},{"key":"10.1016\/j.vaccine.2021.10.020_b0040","unstructured":"Sinovac Biotech Ltd. Summary of Clinical Trial Data of Sinovac\u2019s COVID-19 Vaccine. [Internet]. 2021 April 3 [cited 2021 Apr 21]; Available from: http:\/\/www.sinovac.com\/?optionid=754&auto_id=927."},{"key":"10.1016\/j.vaccine.2021.10.020_b0045","unstructured":"CanSinoBIO. NMPA Accepts the Application for Conditional Marketing Authorization of CanSinoBIO\u2019s COVID-19 Vaccine ConvideciaTM. [Internet]. 2021 Feb 24 [cited 2021 Apr 21]; Available from: http:\/\/www.cansinotech.com\/html\/1\/\/\/179\/180\/651.html."},{"key":"10.1016\/j.vaccine.2021.10.020_b0050","unstructured":"Chinese National Radio. Results of Phase I and Phase II clinical trials of recombinant protein novel coronavirus vaccine in China were released. \u6211\u56fd\u91cd\u7ec4\u86cb\u767d\u65b0\u51a0\u75c5\u6bd2\u75ab\u82d7I\u671f\u3001II\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7ed3\u679c\u53d1\u5e03 [Internet]. 2021 27 Mar [cited 2021 Apr 21]. Available from: http:\/\/news.cnr.cn\/native\/gd\/20210327\/t20210327_525447468.shtml."},{"key":"10.1016\/j.vaccine.2021.10.020_b0055","unstructured":"Central People's Government of the People's Republic of China. Public likely to receive vaccines in February. [Internet]. Beijing China Daily; 2021 14 Jan [cited 2021 January 29]. Available from: http:\/\/english.www.gov.cn\/statecouncil\/ministries\/202101\/14\/content_WS5fff9729c6d0f72576943cda.html."},{"key":"10.1016\/j.vaccine.2021.10.020_b0060","unstructured":"China Daily. China encourages voluntary COVID-19 vaccination: official. [Internet]. 2021 12 April [cited 2021 June 8]. Available from: http:\/\/www.chinadaily.com.cn\/a\/202104\/12\/WS6073a294a31024ad0bab4ce6.html."},{"key":"10.1016\/j.vaccine.2021.10.020_b0065","unstructured":"Central People's Government of the People's Republic of China. COVID-19 Vaccination Status (As of 6 June). \u65b0\u51a0\u75c5\u6bd2\u75ab\u82d7\u63a5\u79cd\u60c5\u51b5\uff08\u622a\u81f36\u67086\u65e5)[Internet]. 2021 7 June [cited 2021 June 8]. Available from: http:\/\/www.gov.cn\/xinwen\/2021-06\/07\/content_5615979.htm."},{"key":"10.1016\/j.vaccine.2021.10.020_b0070","unstructured":"China Central Television. Mass COVID-19 vaccination begins as China to vaccinate 40% of its population by June. [Internet]. 2021 21 Mar [cited 2021 March 24]. Available from: https:\/\/english.cctv.com\/2021\/03\/06\/ARTIGqJwZRSuIVanbUO67viI210306.shtml."},{"key":"10.1016\/j.vaccine.2021.10.020_b0075","doi-asserted-by":"crossref","unstructured":"Lippi G, Henry BM. How will emerging SARS-CoV-2 variants impact herd immunity? Annals of translational medicine [Internet]. 2021 Apr [cited 2021 Jun 8];9(7):585. Available from: https:\/\/atm.amegroups.com\/article\/view\/66312\/html.","DOI":"10.21037\/atm-21-893"},{"key":"10.1016\/j.vaccine.2021.10.020_b0080","doi-asserted-by":"crossref","unstructured":"Wang C, Han B, Zhao T, Liu H, Liu B, Chen L, et al. Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study. Vaccine [Internet]. 2021 Jan 1 [cited 2021 Apr 27]; Available from: https:\/\/europepmc.org\/article\/PMC\/PMC8043613.","DOI":"10.1016\/j.vaccine.2021.04.020"},{"key":"10.1016\/j.vaccine.2021.10.020_b0085","doi-asserted-by":"crossref","unstructured":"MacDonald NE. Vaccine hesitancy: Definition, scope and determinants. Vaccine [Internet]. 2015 Aug 14 [cited 2021 Jun 8];33(34):4161\u20134. Available from: https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.036","DOI":"10.1016\/j.vaccine.2015.04.036"},{"key":"10.1016\/j.vaccine.2021.10.020_b0090","doi-asserted-by":"crossref","unstructured":"Attwell K, Dube E, Gagneur A, Omer SB, Suggs LS, Thomson A. Vaccine acceptance: Science, policy, and practice in a \u2018post-fact\u2019 world. [Internet] Vaccine. 2019 [cited 2021 Jun 8];37(5):677\u201382. Available from: https:\/\/doi.org\/10.1016\/j.vaccine.2018.12.014.","DOI":"10.1016\/j.vaccine.2018.12.014"},{"key":"10.1016\/j.vaccine.2021.10.020_b0095","doi-asserted-by":"crossref","unstructured":"Attwell K, Navin MC, Lopalco PL, Jestin C, Reiter S, Omer SB. Recent vaccine mandates in the United States, Europe and Australia: A comparative study. Vaccine [Internet]. 2018 Nov 19 [cited 2021 Apr 22];36(48):7377\u201384. Available from: http: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0264410X18313719.","DOI":"10.1016\/j.vaccine.2018.10.019"},{"key":"10.1016\/j.vaccine.2021.10.020_b0100","doi-asserted-by":"crossref","unstructured":"Vaz OM, Jenness SM, Bednarczyk RA, Omer SB, Ellingson MK, Weiss P, et al. Mandatory vaccination in Europe. Pediatrics [Internet]. [cited 2021 Apr 22];145(2). Available from: https:\/\/pediatrics.aappublications.org\/content\/pediatrics\/early\/2020\/01\/09\/peds.2019-0620.full.pdf.","DOI":"10.1542\/peds.2019-0620"},{"key":"10.1016\/j.vaccine.2021.10.020_b0105","doi-asserted-by":"crossref","unstructured":"Fan Liang. COVID-19 and Health Code: How Digital Platforms Tackle the Pandemic in China. Social Media + Society [Internet]. 2020 Aug 1 [cited 2021 Jan 4];6. Available from: https:\/\/journals.sagepub.com\/doi\/10.1177\/2056305120947657.","DOI":"10.1177\/2056305120947657"},{"key":"10.1016\/j.vaccine.2021.10.020_b0110","doi-asserted-by":"crossref","unstructured":"Liu C. Seeing like a state, enacting like an algorithm: (Re)assembling contact tracing and risk assessment during the COVID-19 pandemic. Science, Technology, and Human Values. [Internet] 2021 Jun 4 [cited 2021 Sep 6]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8180664\/pdf\/10.1177_01622439211021916.pdf.","DOI":"10.1177\/01622439211021916"},{"key":"10.1016\/j.vaccine.2021.10.020_b0115","unstructured":"P\u00e9rez-Troncoso D. A step-by-step guide to design, implement, and analyze a discrete choice experiment. 2020 [cited 2021 Jan 4]; Available from: https:\/\/arxiv.org\/pdf\/2009.11235.pdf."},{"key":"10.1016\/j.vaccine.2021.10.020_b0120","unstructured":"World Health Organization (WHO). Vaccine Hesitancy: what it means and what we need to know in order to tackle it. [Internet] 2021 Mar [cited 2021 Aug 31]; Available from: https:\/\/www.who.int\/immunization\/research\/forums_and_initiatives\/1_RButler_VH_Threat_Child_Health_gvirf16.pdf."},{"key":"10.1016\/j.vaccine.2021.10.020_b0125","doi-asserted-by":"crossref","unstructured":"Reed Johnson F, Lancsar E, Marshall D, Kilambi V, M\u00fchlbacher A, Regier DA, et al. Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value in Health [Internet]. 2013 Jan 1 [cited 2021 Jan 4];16(1):3\u201313. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1098301512041629.","DOI":"10.1016\/j.jval.2012.08.2223"},{"key":"10.1016\/j.vaccine.2021.10.020_b0130","doi-asserted-by":"crossref","unstructured":"Vaske JJ, Jacobs MH, Sijtsma MTJ, Beaman J. Can Weighting Compensate for Sampling Issues in Internet Surveys? Human Dimensions of Wildlife. [Internet]. 2011 [cited 2021 Jan 4];16(3):200-15. Available from: https:\/\/doi.org\/10.1080\/10871209.2011.571230.","DOI":"10.1080\/10871209.2011.571230"},{"key":"10.1016\/j.vaccine.2021.10.020_b0135","unstructured":"Van de Kerckhove W, Mohadjer L, Krenzke T. A weight trimming approach to achieve a comparable increase to bias across countries in the programme for international assessment of adult competencies. JSM Proceedings, Survey Research Methods Section. Alexandria, VA: American Statistical Association. [Internet] 2014 [cited 2021 Aug 28]:655-66. Available from: http:\/\/www.asasrms.org\/Proceedings\/y2014\/files\/311170_87007.pdf."},{"key":"10.1016\/j.vaccine.2021.10.020_b0140","unstructured":"Chowdhury S, Khare M, Wolter K. Weight Trimming in the National Immunization Survey. [Internet] 2007 Jan [cited 2021 Aug 31]; Available from: http:\/\/www.asasrms.org\/Proceedings\/y2007\/Files\/JSM2007-000077.pdf."},{"key":"10.1016\/j.vaccine.2021.10.020_b0145","doi-asserted-by":"crossref","unstructured":"Yves Croissant. Estimation of Random Utility Models in R: The mlogit Package. Journal of Statistical Software [Internet]. 2020 Oct 1 [cited 2021 Jun 8];95(1):1\u201341. Available from: https:\/\/www.jstatsoft.org\/article\/view\/v095i11.","DOI":"10.18637\/jss.v095.i11"},{"key":"10.1016\/j.vaccine.2021.10.020_b0150","doi-asserted-by":"crossref","unstructured":"Knol MJ, Pestman WR, Grobbee DE. The (mis)use of overlap of confidence intervals to assess effect modification. European Journal of Epidemiology: Affiliated to the European Epidemiology Federation [Internet]. 2011 [cited 2021 Aug 6];26(4):253. Available from: https:\/\/link.springer.com\/article\/10.1007\/s10654-011-9563-8.","DOI":"10.1007\/s10654-011-9563-8"},{"key":"10.1016\/j.vaccine.2021.10.020_b0155","unstructured":"Ye X. The Delta Method to Compute Confidence Intervals of Predictions from Discrete Choice Model : An Application to Commute Mode Choice Model. Semantic Scholar [Internet]. 2013 [cited 2021 Apr 28]; Available from: http:\/\/rampendyala.weebly.com\/uploads\/5\/0\/5\/4\/5054275\/5035_deltamethod_yependyala.pdf."},{"key":"10.1016\/j.vaccine.2021.10.020_b0160","unstructured":"Healthline. How much will it cost to get a COVID-19 Vaccine? [Internet]. 2020 Dec [cited 2021 March 24]. Available from: https:\/\/www.healthline.com\/health-news\/how-much-will-it-cost-to-get-a-covid-19-vaccine."},{"key":"10.1016\/j.vaccine.2021.10.020_b0165","unstructured":"CBC NEWS. AstraZeneca says advanced trial shows its COVID-19 vaccine is 79% effective. [Internet]. 2021 Mar [cited 2021 March 24]. Available from: https:\/\/www.cbsnews.com\/news\/astrazeneca-oxford-covid-vaccine-79-percent-effective-advanced-trial\/."},{"key":"10.1016\/j.vaccine.2021.10.020_b0170","unstructured":"Ebbs, S and Salzman, S. Single-dose Johnson & Johnson vaccine effective against COVID-19 variants: Data. ABC NEWs, [Internet]. 2021 Feb [cited 2021 March 24]. Available from: https:\/\/abcnews.go.com\/Politics\/single-dose-johnson-johnson-vaccine-effective-variants-data\/story?id=76084549."},{"key":"10.1016\/j.vaccine.2021.10.020_b0175","unstructured":"Wagner AL, Montgomery JP, Boulton ML, Xu W. Influenza vaccination of adults with and without high-risk health conditions in China. Journal of Public Health (United Kingdom) [Internet]. 2016 May 8 [cited 2021 Jun 18];39(2):358\u201365. Available from: https:\/\/academic.oup.com\/jpubhealth\/article\/39\/2\/358\/3002968."},{"key":"10.1016\/j.vaccine.2021.10.020_b0180","doi-asserted-by":"crossref","unstructured":"Thomson A, Robinson K, Vall\u00e9e-Tourangeau G. The 5As: A practical taxonomy for the determinants of vaccine uptake. Vaccine [Internet]. 2016 Feb 17 [cited 2021 Jun 8];34(8):1018\u201324. Available from: https:\/\/doi.org\/10.1016\/j.vaccine.2015.11.065.","DOI":"10.1016\/j.vaccine.2015.11.065"},{"key":"10.1016\/j.vaccine.2021.10.020_b0185","unstructured":"Fan, Y. Chinese Province Launches Gold \u2018Health Code\u2019 for Vaccine Recipients. Sixth Tone. [Internet]. 2021 May 2 [cited 2021 May 8]; Available from: https:\/\/www.sixthtone.com\/news\/1007379\/Chinese%20Province%20Launches%20Gold%20%E2%80%98Health%20Code%E2%80%99%20for%20Vaccine%20Recipients."},{"key":"10.1016\/j.vaccine.2021.10.020_b0190","doi-asserted-by":"crossref","unstructured":"Lu J, Wen X, Guo Q, Ji M, Zhang F, Wagner AL, et al. Sensitivity to COVID-19 Vaccine Effectiveness and Safety in Shanghai, China. Vaccines [Internet]. 2021 May 1 [cited 2021 Jun 8];9(472):472. Available from: https:\/\/europepmc.org\/article\/MED\/34067141.","DOI":"10.3390\/vaccines9050472"},{"key":"10.1016\/j.vaccine.2021.10.020_b0195","doi-asserted-by":"crossref","unstructured":"Liu C and Graham R. Making sense of algorithms: Relational perception of contact tracing and risk assessment during COVID-19. Big Data & Society [Internet]. 2021 Feb 1 [cited 2021 Jun 8];8. Available from: https:\/\/doi.org\/10.1177\/2053951721995218.","DOI":"10.1177\/2053951721995218"},{"key":"10.1016\/j.vaccine.2021.10.020_b0200","unstructured":"WildChina. How To Travel Domestically In China: Green Codes and Health Kits in China\u2019s COVID-19 Response. [Internet] 2021 Jan [cited 2021 June 18]; Available from: https:\/\/wildchina.com\/2021\/01\/green-codes-and-health-kits-in-china\/."},{"key":"10.1016\/j.vaccine.2021.10.020_b0205","unstructured":"The National People's Congress of the People's Republic of China. Vaccine Administration Law of the People\u2019s Republic of China. [Internet]. 2019 June 29 [cited 2021 Jun 8] Available from: http:\/\/www.npc.gov.cn\/englishnpc\/c23934\/202012\/0b1fd779c29e49bd99eb0e65b66aa783.shtml."},{"key":"10.1016\/j.vaccine.2021.10.020_b0210","unstructured":"Bloomberg News. China Calls For Haltto Mandatory Vaccines Amid Inoculation Push. [Internet]. 2021 April 12 [cited 2021 Jun 8] Available from: https:\/\/www.bloombergquint.com\/business\/china-calls-for-halt-to-mandatory-vaccines-amid-inoculation-push."},{"key":"10.1016\/j.vaccine.2021.10.020_b0215","unstructured":"World Health Organization (WHO). WHO Coronavirus Disease (COVID-19) Dashboard: China situation [Internet] 2020 May 1 [cited 2021 June 18]; Available from: https:\/\/covid19.who.int\/region\/wpro\/country\/cn."},{"key":"10.1016\/j.vaccine.2021.10.020_b0220","doi-asserted-by":"crossref","unstructured":"Yang R, Penders B, Horstman K. Addressing Vaccine Hesitancy in China: A Scoping Review of Chinese Scholarship. Vaccines [Internet]. 2019 Dec 20 [cited 2021 Jun 8];8(1). Available from: https:\/\/doi.org\/10.3390\/vaccines8010002.","DOI":"10.3390\/vaccines8010002"},{"key":"10.1016\/j.vaccine.2021.10.020_b0225","doi-asserted-by":"crossref","unstructured":"Zhuang J, Lu Y, Jiang Q, Wagner AL. Profit considerations in vaccine safety-related events in China. Expert Review of Vaccines [Internet]. 2019 Nov 13 [cited 2021 Jun 18];18(11):1187\u201399. Available from: https:\/\/doi.org\/10.1080\/14760584.2019.1688150.","DOI":"10.1080\/14760584.2019.1688150"},{"key":"10.1016\/j.vaccine.2021.10.020_b0230","unstructured":"Centers for Disease Control and Prevention (CDC). Information about COVID-19 Vaccines for People with Allergies. [Internet]. 2021 Mar 25 [cited 2021 Apr 21]; Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations\/specific-groups\/allergies.html."},{"key":"10.1016\/j.vaccine.2021.10.020_b0235","doi-asserted-by":"crossref","unstructured":"Attwell K and Navin MC. Childhood Vaccination Mandates: Scope, Sanctions, Severity, Selectivity, and Salience. The Milbank Quarterly [Internet]. 2019 Dec 1 [cited 2021 Jun 8];97(4):978\u20131014. Available from: https:\/\/doi.org\/10.1111\/1468-0009.12417.","DOI":"10.1111\/1468-0009.12417"},{"key":"10.1016\/j.vaccine.2021.10.020_b0240","doi-asserted-by":"crossref","unstructured":"Vaz OM, Jenness SM, Bednarczyk RA, Omer SB, Ellingson MK, Weiss P, et al. Mandatory vaccination in Europe. Pediatrics [Internet]. [cited 2021 Jun 8];145(2). Available from: https:\/\/pediatrics.aappublications.org\/content\/pediatrics\/early\/2020\/01\/09\/peds.2019-0620.full.pdf.","DOI":"10.1542\/peds.2019-0620"},{"key":"10.1016\/j.vaccine.2021.10.020_b0245","unstructured":"Central People's Government of the People's Republic of China. The State Council has established a joint prevention and control mechanism for free vaccination: A total of more than 9 million doses of COVID-19 vaccine have been administered nationwide. \u56fd\u52a1\u9662\u8054\u9632\u8054\u63a7\u673a\u5236\u660e\u786e\u5b9e\u884c\u514d\u8d39\u63a5\u79cd\u75ab\u82d7 \u5168\u56fd\u7d2f\u8ba1\u5f00\u5c55\u65b0\u51a0\u75ab\u82d7\u63a5\u79cd900\u591a\u4e07\u5242\u6b21. [Internet]. 2021 Jan 10 [cited 2021 June 18]. Available from: http:\/\/www.gov.cn\/xinwen\/2021-01\/10\/content_5578578.htm."},{"key":"10.1016\/j.vaccine.2021.10.020_b0250","doi-asserted-by":"crossref","unstructured":"Clark MD, Determann D, Petrou S, Moro D, de Bekker-Grob EW. Discrete Choice Experiments in Health Economics: A Review of the Literature. PharmacoEconomics [Internet]. 2014 [cited 2021 Apr 1];32(9):883. Available from: https:\/\/doi.org\/10.1007\/s40273-014-0170-x.","DOI":"10.1007\/s40273-014-0170-x"},{"key":"10.1016\/j.vaccine.2021.10.020_b0260","unstructured":"National Bureau of Statistics. China statistical yearbook 2018, China Statistics Press [Internet]. 2018 Dec [cited 2021 January 4] Available from: http:\/\/www.stats.gov.cn\/tjsj\/ndsj\/2018\/indexeh.htm."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21013402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21013402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:20:10Z","timestamp":1759404010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21013402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":51,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0264410X21013402"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.10.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Would COVID-19 vaccination willingness increase if mobile technologies prohibit unvaccinated individuals from public spaces? A nationwide discrete choice experiment from China","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}